Kampon Sriwatanakul
Asian Institute of Regenerative Medicine, Thailand
Title: Applications of stem cell therapy in regenerative medicine in Asian countries
Biography
Biography: Kampon Sriwatanakul
Abstract
Stem cell therapy is an emerging form of healthcare that offers significant potential to improve the practice of medicine. Despite the large number of cell therapy are in clinical trials, relatively few have made it to the market in the United States. In Asia, Korea seems to develop cell therapy products more rapidly than other countries. In Asian countries, we attempt to promote the applications of stem cell therapy in regenerative medicine. The PRP (Platelet Rich Plasma) kit is currently in the process of seeking FDA approval as a Class II medical device. Clinical trials were conducted to demonstrate the efficacy and safety of this innovative kit in the treatments of facial rejuvenation and mild to moderate cases of knee joint osteoarthritis (OA). The results demonstrated the consistent effects in stimulating cell proliferation and tissue regeneration. There were statistically significant differences regarding the general appearance, facial skin firmness, sagging and wrinkle states before each PRP procedure and 3 months after the last PRP procedure. The intra-articular injection of hyaluronic acid (HA) plus PRP could strongly rescue the meniscus tear and cartilage breakdown. The combination of HA and PRP can synergistically promote cartilage regeneration and inhibit OA inflammation. These studies might offer advanced treatments for facial rejuvenation and alternative OA treatments based on regenerative mechanisms.